This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Brown P, Pieters R, Biondi A. How I treat infant leukemia. Blood. 2019;133:205–14.
Katsanis E, Sapp LN, Reid SC, Reddivalla N, Stea B. T-cell replete myeloablative haploidentical bone marrow transplantation is an effective option for pediatric and young adult patients with high-risk hematologic malignancies. Front Pediatr. 2020;8:282.
Truscott L, Pariury H, Hanmod S, Davini M, de la Maza M, Sapp LN, et al. Busulfan, fludarabine, and melphalan are effective conditioning for pediatric and young adult patients with myeloid malignancies underdoing matched sibling or alternative donor transplantation. Pediatr Blood Cancer. 2023;70:e30102.
Katsanis E, Stea B, Kovacs K, Truscott L, Husnain M, Khurana S, et al. Feasibility and efficacy of partially replacing post-transplantation cyclophosphamide with bendamustine in pediatric and young adult patients undergoing haploidentical bone marrow transplantation. Transplant Cell Ther. 2022;28:390.e1–e10.
Katsanis E, Sapp LN, Varner N, Koza S, Stea B, Zeng Y. Haploidentical bone marrow transplantation with post-transplant cyclophosphamide/bendamustine in pediatric and young adult patients with hematologic malignancies. Biol Blood Marrow Transplant. 2018;24:2034–9.
Kato M, Hasegawa D, Koh K, Kato K, Takita J, Inagaki J, et al. Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia with KMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia working group of the Japan Society for Haematopoietic Cell Transplantation. Br J Haematol. 2015;168:564–70.
Ochoa-Fernandez B, Galan-Gomez V, Guerra-Garcia P, Sanroman S, Martinez I, Bueno D, et al. Younger age and induction failure predict outcomes in infant leukemia: 30 years of experience in a tertiary center. Front Pediatr. 2023;11:1166176.
Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant. 2018;53:138–45.
Philippe M, Neely M, Rushing T, Bertrand Y, Bleyzac N, Goutelle S. Maximal concentration of intravenous busulfan as a determinant of veno-occlusive disease: a pharmacokinetic-pharmacodynamic analysis in 293 hematopoietic stem cell transplanted children. Bone Marrow Transplant. 2019;54:448–57.
Bartelink IH, Lalmohamed A, van Reij EM, Dvorak CC, Savic RM, Zwaveling J, et al. Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis. Lancet Haematol. 2016;3:e526–36.
Higham CS, Collins G, Shimano KA, Melton A, Kharbanda S, Winestone LE, et al. Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis. Blood Adv. 2021;5:2106–14.
Jodele S, Dandoy CE, Lane A, Laskin BL, Teusink-Cross A, Myers KC, et al. Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab. Blood. 2020;135:1049–57.
Acknowledgements
The authors wish to thank the inpatient and outpatient APPs, nursing and other staff on the pediatric HCTT unit at Diamond Children’s/Banner University Medical Center in Tucson for their outstanding care of our patients.
Author information
Authors and Affiliations
Contributions
DF wrote the manuscript. LT and NR treated the patients prior to HCT and referred them for HCT and edited the manuscript. EK managed the patients throughout their HCT course, collected and analyzed the data and co-wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Filioglou, D., Truscott, L., Reddivalla, N. et al. Outcomes of haploidentical bone marrow transplantation in infant acute leukemia: a single center experience. Bone Marrow Transplant (2024). https://doi.org/10.1038/s41409-024-02281-8
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41409-024-02281-8